Skip to main content

Exercise and proper sleep can reduce cancer risk

The latest research shows that proper exercise which should be regulated ( Like 30mins daily ) and proper sleep can reduce cancer risks. Because, daily exercise maintains body metabolism in a steady way and this prevents altered metabolism within our body. Also, proper sleep which should be at least 6 hours at night can reduces the altered endocrine and metabolic functions. So, proper sleep is very important. This all can reduce cancer risks upto 55%.

Comments

Popular posts from this blog

Natural killer cell = The wonder creation , may be a mutation of WBC......

Natural killer cell From Wikipedia, the free encyclopedia   (Redirected from Natural Killer cell ) Jump to: navigation , search Natural killer cells (or NK cells ) are a type of cytotoxic lymphocyte critical to the innate immune system . The role NK cells play is analogous to that of cytotoxic T cells in the vertebrate adaptive immune response . NK cells provide rapid responses to virally infected cells and respond to tumor formation, acting at around 3 days after infection . Typically immune cells detect MHC presented on infected cell surfaces, triggering cytokine release causing lysis or apoptosis . NK cells are unique, however, as they have the ability to recognize stressed cells in the absence of antibodies and MHC, allowing for a much faster immune reaction. They were named “natural killers” because of the initial notion that they do not require activation in order...

Erythropoietin as a Retinal Angiogenic Factor in Proliferative Diabetic Retinopathy

Although vascular endothelial growth factor (VEGF) is a primary mediator of retinal angiogenesis, VEGF inhibition alone is insufficient to prevent retinal neovascularization. Hence, it is postulated that there are other potent ischemia-induced angiogenic factors. Erythropoietin possesses angiogenic activity, but its potential role in ocular angiogenesis is not established. METHODS We measured both erythropoietin and VEGF levels in the vitreous fluid of 144 patients with the use of radioimmunoassay and enzyme-linked immunosorbent assay. Vitreous proliferative potential was measured according to the growth of retinal endothelial cells in vitro and with soluble erythropoietin receptor. In addition, a murine model of ischemia-induced retinal neovascularization was used to evaluate erythropoietin expression and regulation in vivo. RESULTS The median vitreous erythropoietin level in 73 patients with proliferative diabetic retinopathy was significantly higher than that in 71 patients with...

Artificial pancreas ... an option

Coming Soon: 'Artificial Pancreas' Options for Diabetes Miriam E Tucker June 20, 2016   NEW ORLEANS — Nearly closed-loop systems (also referred to as an "artificial pancreas") for improving glycemic control and minimizing hypoglycemia in type 1 diabetes are advancing rapidly, including iterations that deliver insulin alone, insulin with glucagon, or glucagon alone. Findings for several of the products in development demonstrating improvements in glycemic control and reductions in hypoglycemia were presented here at the  American Diabetes Association (ADA) 2016 Scientific Sessions . "Some people may do well on insulin only, while others may need glucagon," Vincent Crabtree, PhD, director of the artificial pancreas program at JDRF, in New York, told  Medscape Medical News , adding, "JDRF would like people to have choice, and we'd like all to be covered [by payers]." The insulin-only hybrid closed-loop 670G system (Medtronic MiniMed) is the...